| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
Revenue  | 1,921 | 2,103 | 2,067 | 2,083 | 2,249 | 2,336 | 2,320 | 2,674 | 2,526 | 2,374 | 2,627 |
| Expenses | 1,470 | 1,586 | 1,617 | 1,468 | 1,516 | 1,579 | 1,526 | 1,775 | 1,616 | 1,558 | 1,541 |
| EBITDA | 450 | 517 | 450 | 615 | 733 | 757 | 793 | 898 | 910 | 816 | 1,085 |
| Operating Profit % | 21 % | 21 % | 18 % | 25 % | 27 % | 27 % | 32 % | 32 % | 33 % | 29 % | 32 % |
| Depreciation | 131 | 124 | 63 | 66 | 71 | 103 | 109 | 115 | 106 | 62 | 61 |
| Interest | 1 | 1 | 1 | 0 | 1 | 11 | 15 | 11 | 13 | 15 | 8 |
| Profit Before Tax | 238 | 402 | 517 | 548 | 660 | 643 | 669 | 773 | 824 | 746 | 1,016 |
| Tax | 138 | 179 | 180 | 188 | 231 | 133 | 171 | 160 | 200 | 195 | 264 |
| Net Profit | 100 | 223 | 337 | 360 | 429 | 509 | 498 | 613 | 624 | 551 | 768 |
| EPS in ₹ | 15.26 | 66.66 | 73.61 | 78.70 | 93.78 | 111.28 | 108.77 | 133.89 | 136.38 | 120.51 | 167.80 |
Pfizer
5,882.50
-6.50
(-0.11%)
Market Cap
26,911.10 Cr
EPS
120.51
PE Ratio
42.11
Dividend Yield
2.80 %
Industry
Healthcare52 Week High
6,451.15
52 Week Low
3,701.00
PB Ratio
6.39
Debt to Equity
0.01
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,687.80 | #1 4,04,959.76 | 35.29 | #1 49,887.20 | 12.06 | #1 9,648 | -18.99 | 46.16 | |
6,667.00 | 1,76,987.90 | 81.46 | 8,184.00 | 0.89 | 1,600 | 23.05 | 60.61 | |
1,505.20 | 1,21,562.20 | 23.01 | 26,520.70 | 14.17 | 4,155 | 30.28 | 53.87 | |
1,362.50 | 1,13,694.54 | 20.11 | 28,905.40 | 12.36 | 5,578 | 21.14 | 84.56 | |
3,252.50 | 1,10,079.38 | 57.23 | 10,785.70 | 11.59 | 1,656 | 10.91 | 56.97 | |
2,381.30 | 98,247.32 | 49.58 | 10,615.60 | 19.57 | 1,942 | -10.91 | 43.09 | |
974.95 | 98,102.78 | 21.09 | 19,831.50 | 13.82 | 3,831 | -0.19 | 71.52 | |
1,999.60 | 91,289.93 | 28.14 | 20,141.50 | #1 19.94 | 1,936 | #1 112.49 | 49.72 | |
31,515.00 | 66,967.18 | 47.29 | 6,097.20 | 10.80 | 1,201 | 27.83 | 59.42 | |
1,150.20 | 66,803.80 | #1 19.42 | 29,559.20 | 17.55 | 3,169 | -0.50 | 44.60 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
-6.02 %
Net Income Growth
-11.64 %
Cash Flow Change
-27.79 %
ROE
-21.18 %
ROCE
-17.45 %
EBITDA Margin (Avg.)
-4.58 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 2,612 | 2,914 | 3,261 | 3,690 | 3,940 | 4,405 | 3,266 | 3,901 | 4,001 | 4,229 |
| Fixed Assets | 944 | 895 | 902 | 950 | 886 | 973 | 894 | 869 | 749 | 713 |
| Current Assets | 1,253 | 1,630 | 2,051 | 2,417 | 2,715 | 3,048 | 1,925 | 2,397 | 2,493 | 2,738 |
| Capital Work in Progress | 13 | 3 | 15 | 1 | 0 | 1 | 3 | 1 | 8 | 0 |
| Investments | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,655 | 2,011 | 2,343 | 2,739 | 3,054 | 3,432 | 2,369 | 3,030 | 3,244 | 3,516 |
| Total Liabilities | 2,612 | 2,914 | 3,261 | 3,690 | 3,940 | 4,405 | 3,266 | 3,901 | 4,001 | 4,229 |
| Current Liabilities | 606 | 759 | 780 | 954 | 892 | 873 | 774 | 853 | 657 | 547 |
| Non Current Liabilities | 32 | 36 | 62 | 52 | 37 | 137 | 99 | 183 | 136 | 87 |
| Total Equity | 1,973 | 2,118 | 2,419 | 2,683 | 3,011 | 3,396 | 2,393 | 2,864 | 3,207 | 3,596 |
| Reserve & Surplus | 1,927 | 2,072 | 2,373 | 2,637 | 2,966 | 3,350 | 2,347 | 2,819 | 3,162 | 3,550 |
| Share Capital | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 181 | -417 | -4 | -17 | 23 | 1,690 | -1,613 | -88 | -26 | 75 |
| Investing Activities | 68 | -701 | -250 | -238 | 35 | 1,530 | -469 | -575 | -36 | 54 |
| Operating Activities | 114 | 346 | 329 | 332 | 98 | 323 | 427 | 667 | 356 | 257 |
| Financing Activities | -1 | -62 | -83 | -110 | -110 | -164 | -1,571 | -181 | -346 | -235 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 2.82 % | 0.00 % | 3.33 % | 3.22 % | 3.54 % | 2.75 % | 2.18 % |
| DIIs | 13.08 % | 8.98 % | 8.98 % | 8.84 % | 8.57 % | 7.91 % | 14.85 % | 14.93 % | 14.89 % | 14.89 % | 15.01 % | 15.15 % | 15.33 % | 15.84 % | 16.03 % | 16.79 % | 17.10 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 15.03 % | 14.11 % | 14.11 % | 14.25 % | 14.19 % | 14.08 % | 13.94 % | 13.71 % | 13.70 % | 13.69 % | 13.61 % | 13.21 % | 12.90 % | 12.55 % | 12.15 % | 12.12 % | 12.34 % |
| Others | 7.97 % | 12.98 % | 12.98 % | 12.99 % | 13.32 % | 14.08 % | 7.29 % | 7.43 % | 7.49 % | 7.50 % | 4.64 % | 7.72 % | 4.52 % | 4.46 % | 4.35 % | 4.41 % | 4.45 % |
| No of Share Holders | 1,45,980 | 1,21,153 | 1,21,153 | 1,26,808 | 1,25,287 | 1,23,449 | 1,22,028 | 1,17,950 | 1,17,194 | 1,15,988 | 1,16,948 | 1,12,456 | 1,09,214 | 1,06,098 | 98,824 | 1,05,015 | 1,08,261 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 20 | 20 | 22.5 | 330 | 35 | 35 | 70 | 35 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.92 | 0.6 | 0.56 | 7.29 | 0.8 | 1 | 1.67 | 0.87 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 21 Jul 2025 |  Annual General Meeting | NA | 21 Jul 2025 | 4,411.35 | 5,883.10 |
| 09 Jul 2025 |  Dividend | ₹ 100.00 /share | 09 Jul 2025 | 4,411.35 | 5,883.10 |
| 09 Jul 2025 | Dividend | ₹ 35.00 /share | 09 Jul 2025 | 4,411.35 | 5,883.10 |
| 19 May 2025 |  Quarterly Result Announcement | NA | 19 May 2025 | 4,249.90 | 4,411.35 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 4,784.65 | 4,516.55 |
| 28 Oct 2024 | Quarterly Result Announcement | NA | 28 Oct 2024 | 5,673.00 | 5,308.70 |
| 28 Aug 2024 | Annual General Meeting | NA | 28 Aug 2024 | 5,842.95 | 5,862.80 |
| 21 Aug 2024 | Dividend | ₹ 35.00 /share | 21 Aug 2024 | 4,335.90 | 5,901.90 |
| 11 Aug 2023 | Dividend | ₹ 5.00 /share | 11 Aug 2023 | 3,772.20 | 4,038.75 |
| 11 Aug 2023 | Dividend | ₹ 35.00 /share | 11 Aug 2023 | 3,772.20 | 4,038.75 |
| 20 Feb 2022 | Dividend | ₹ 30.00 /share | 19 Sept 2022 | 4,277.45 | 4,346.40 |
| 19 Aug 2022 | Dividend | ₹ 35.00 /share | 18 Aug 2022 | 4,261.65 | 4,215.30 |
| 13 Aug 2021 | Dividend | ₹ 5.00 /share | 11 Aug 2021 | 5,251.65 | 5,820.45 |
| 13 Aug 2021 | Dividend | ₹ 30.00 /share | 11 Aug 2021 | 5,251.65 | 5,820.45 |
Announcements
Compliances-Reg.24(A)-Annual Secretarial Compliance
May 23, 2025
May 23, 2025Appointment Of Cost And Secretarial AuditorMay 19, 2025
May 19, 2025Intimation Of Date Of Annual General MeetingMay 19, 2025
May 19, 2025Corporate Action-Board approves DividendMay 19, 2025
May 19, 2025Board Meeting Outcome for Outcome Of Board MeetingMay 19, 2025
May 19, 2025Board Meeting Intimation for Board Meeting To Consider And Approve The Audited Financial Results For The Quarter And Financial Year Ended March 31 2025.May 13, 2025
May 13, 2025Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 29, 2025
Apr 29, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Apr 11, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 01, 2025
Apr 01, 2025Closure of Trading WindowMar 31, 2025
Mar 31, 2025Update On Transfer And Assignment Of PfizerS Unexpired Leasehold Rights In The Land Situated At Plot No. 16 Trans Thane Creek Industrial Area Turbhe Thane And Sale Of
Structures And Buildings Constructed Thereon To Zoetis Pharmaceutical Research Private Mar 29, 2025
Mar 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 19, 2025
Mar 19, 2025Board Meeting Outcome for Marketing And Supply Agreement With Mylan Pharmaceuticals Private LimitedFeb 21, 2025
Feb 21, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 14, 2025
Feb 14, 2025Receipt Of GST Order Levying Tax Demand And PenaltyFeb 05, 2025
Feb 05, 2025Receipt Of GST Order Levying Tax Demand And PenaltyFeb 05, 2025
Feb 05, 2025Receipt Of GST Order For A Tax Demand Interest And PenaltyFeb 04, 2025
Feb 04, 2025Levy Of Tax Demand And PenaltyFeb 03, 2025
Feb 03, 2025Integrated Filing (Financial)Feb 01, 2025
Feb 01, 2025Update On Transfer And Assignment Of PfizerS Unexpired Leasehold Rights In The Land Situated At Plot No. 16 Trans Thane Creek Industrial Area Turbhe Thane To Zoetis Pharmaceutical Research Private LimFeb 01, 2025
Feb 01, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJan 31, 2025
Jan 31, 2025Board Meeting Outcome for Outcome Of The Board Meeting- Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 31, 2025
Jan 31, 2025Board Meeting Intimation for Board Meeting To Consider And Take On Record The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 24, 2025
Jan 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Jan 14, 2025Closure of Trading WindowDec 30, 2024
Dec 30, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 17, 2024
Dec 17, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 11, 2024
Dec 11, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 03, 2024
Dec 03, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 19, 2024
Nov 19, 2024Announcement under Regulation 30 (LODR)-Change in ManagementNov 14, 2024
Nov 14, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 12, 2024
Nov 12, 2024Announcement under Regulation 30 (LODR)-Change in DirectorateNov 10, 2024
Nov 10, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 07, 2024
Nov 07, 2024Announcement under Regulation 30 (LODR)-Change in ManagementNov 05, 2024
Nov 05, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 05, 2024
Nov 05, 2024Statement Of Related Party Transactions For The Half Year Ended September 30, 2024Oct 28, 2024
Oct 28, 2024Board Meeting Outcome for Outcome Of The Board Meeting-Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024Oct 28, 2024
Oct 28, 2024Board Meeting Intimation for To Consider And Take On Record The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024.Oct 21, 2024
Oct 21, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 16, 2024
Oct 16, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 08, 2024
Oct 08, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 08, 2024
Oct 08, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 02, 2024
Oct 02, 2024Closure of Trading WindowSep 30, 2024
Sep 30, 2024Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Aug 31, 2024
Aug 31, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 29, 2024
Aug 29, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMAug 28, 2024
Aug 28, 2024Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Aug 14, 2024
Aug 14, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2024
Aug 08, 2024Intimation Of Revised Record Date.Aug 07, 2024
Aug 07, 2024Business Responsibility and Sustainability Reporting (BRSR)Aug 06, 2024
Aug 06, 2024Technical Indicators
RSI(14)
Overbought 81.70
ATR(14)
Less Volatile 150.90
STOCH(9,6)
Neutral 75.76
STOCH RSI(14)
Neutral 28.35
MACD(12,26)
Bearish -1.51
ADX(14)
Very Strong Trend 57.63
UO(9)
Bearish 57.38
ROC(12)
Uptrend And Accelerating 6.74
WillR(14)
Overbought -6.19
Mutual Fund Holdings
| Funding House | No of Shares | Current Holding % | 1M Change % | 3M Change % | Month | |
|---|---|---|---|---|---|---|
 Baroda BNP Paribas Innovation Fund Direct - Growth | 22879 | 1.29% | 1.29% | 1.29% | May 2025 | |
 WhiteOak Capital Pharma and Healthcare Fund Direct - Growth | 9217 | 1.56% | 1.56% | 1.56% | May 2025 | |
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth | 222453 | 2.27% | 0.51% | 0.50% | May 2025 | |
 UTI Healthcare Fund Direct-Growth | 31015 | 1.64% | 0.19% | 0.31% | May 2025 | |
 Bajaj Finserv Multi Cap Fund Direct-Growth | 16615 | 1.34% | 0.31% | 0.23% | May 2025 | |
| Bajaj Finserv ELSS Tax Saver Fund Direct-Growth | 492 | 0.50% | 0.50% | 0.50% | May 2025 | |
| Baroda BNP Paribas Business Cycle Fund Direct - Growth | 6750 | 0.65% | 0.17% | 0.19% | May 2025 | |
| Baroda BNP Paribas Aggressive Hybrid Fund Direct - Growth | 10350 | 0.47% | 0.11% | 0.13% | May 2025 | |
| Baroda BNP Paribas Manufacturing Fund Direct - Growth | 10350 | 0.44% | 0.10% | 0.12% | May 2025 | |
| Baroda BNP Paribas Multi Asset Fund Direct - Growth | 10350 | 0.49% | 0.12% | 0.14% | May 2025 | |
 Nippon India Nifty Smallcap 250 Index Fund Direct - Growth | 18053 | 0.45% | 0.08% | 0.09% | May 2025 | |
 DSP Nifty Smallcap250 Quality 50 Index Fund Direct - Growth | 8933 | 1.96% | 0.30% | 0.40% | May 2025 | |
 SBI Nifty Smallcap 250 Index Fund Direct - Growth | 11321 | 0.45% | 0.08% | 0.09% | May 2025 | |
 Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth | 7314 | 0.45% | 0.07% | 0.09% | May 2025 | |
 HDFC Nifty Smallcap 250 Index Fund Direct-Growth | 3766 | 0.45% | 0.08% | 0.09% | May 2025 | |
| Motilal Oswal Nifty 500 Index Fund Direct - Growth | 1888 | 0.04% | 0.01% | 0.01% | May 2025 | |
| Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth | 1788 | 0.24% | 0.04% | 0.04% | May 2025 | |
 Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth | 1082 | 0.45% | 0.08% | 0.09% | May 2025 | |
 Axis Nifty 500 Index Fund Direct-Growth | 230 | 0.05% | 0.01% | 0.01% | May 2025 | |
| ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth | 3959 | 0.45% | 0.07% | 0.09% | May 2025 | |
 Kotak Nifty Smallcap 250 Index Fund Direct-Growth | 198 | 0.45% | 0.07% | 0.10% | May 2025 | |
 Groww Nifty Smallcap 250 Index Fund Direct - Growth | 887 | 0.45% | 0.07% | 0.09% | May 2025 | |
 Tata Nifty MidSmall Healthcare Index Fund Direct - Growth | 3725 | 1.53% | 0.35% | 0.46% | May 2025 | |
| Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth | 659 | 1.53% | 0.34% | 0.43% | May 2025 | |
 Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth | 58 | 0.11% | 0.02% | 0.02% | May 2025 |
About Pfizer
Pfizer Limited is an Indian pharmaceutical company engaged in manufacturing, marketing, trading, and exporting pharmaceutical products. It has a manufacturing facility in Goa and works with contract manufacturers across India. The company offers a diverse portfolio of products including vaccines, anti-infectives, cardiac medications, pain relief, maternal nutrition, gastrointestinal treatments, contraceptives, anti-inflammatories, and respiratory medicines. Pfizer's key focus areas include vaccines, with Prevenar 13 for pneumococcal prevention, and inflammation and immunology treatments for chronic immune system diseases. The company has undergone several mergers, acquisitions, and divestments over the years, including the merger with Wyeth Limited in 2014 and the sale of certain established medicine brands to Mylan Pharmaceuticals in 2022.
Website
Chairperson NamePradip P Shah
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
